MJBizDaily
Georgia medical cannabis shipped via US mails as market continues rapid growth
Featured
Latest Posts
How to grow marijuana sales organically: Q&A with Organigram CEO Beena Goldenberg
Organigram is among a handful of large Canadian cannabis producers that managed to take more overall share of Canada’s cannabis market in 2021 via nondilutive organic sales growth. How did…
News January 13Opinion: How cannabis brands can cultivate engaged consumers
The market for legal cannabis in the U.S. is expected to surge in the coming years, reaching more than $40 billion annually by 2025, according to the MJBizFactbook, creating huge…
News January 13Incorporate uncertainty into your marijuana business plan
Wouldn’t it be great if words that we’re tired of could just stop being part of our reality? We’ve lived in “unprecedented” and “uncertain” times for nearly two years, thanks…
News January 12Marijuana website Leafly, SPAC partner raise $30M; merger vote delayed
Online marijuana platform Leafly Holdings said it secured $30 million in new funding in relation to its pending merger with special purpose acquisition company (SPAC) Merida Capital Holdings.
News January 12Canadian government hosting cannabis industry diversity forums
The Canadian government is hosting two public forums this month to learn how it can support existing and potential cannabis industry stakeholders from Black, Indigenous and other diverse communities
News January 12Curaleaf director, others sue Oregon CBD startup for $60 million
Investors who include Curaleaf Holdings Executive Chair Boris Jordan filed a $60 million lawsuit alleging they were induced into funding an Oregon CBD startup based on false and misleading information.
News January 12Marijuana company Viola closes $13 million funding round
Los Angeles-based marijuana multistate operator Viola Brands closed a $13 million equity funding round with the aim to expand into several new markets.
News January 12GB Sciences exits cannabis cultivation with $8 million sale of Las Vegas site
Las Vegas-based GB Sciences is leaving the cannabis cultivation space to pursue further interests in the biopharmaceutical industry.
News January 12Outlook dim for US marijuana legalization in 2022, but banking reform alive
The federal marijuana reform landscape in 2022 is cloudy, with most national insiders doubting a comprehensive legalization bill will succeed just yet given the unfavorable political dynamics in Washington DC.
News January 12












